Table 1:

Clinical and imaging characteristics and outcome in 12 patients

Age/SexNIHSS Score on AdmissionOcclusion SiteTime to IV rtPA (min)Time to IA Therapy (min)Duration of Procedure (min)Urokinase Dose (× 104 U)TICI GradeNIHSS at DischargeSymptomatic HemorrhagemRS at 3 Months
70/M13MCA1151706040III6No1
79/M20MCA1232707520IIc2No1
34/F19BA1081707030IIb3No1
73/M20ICAT1202204040IIa9No4
69/F17MCA1272407030IIc1No1
45/M11MCA902404415IIb4No2
72/M13MCA972403030III0No0
72/M17ICAT1753003030IIc6No5
76/M13MCA1301905030III1No1
51/M14MCA1302508040IIc1No1
64/F23BA751908030IIc2No1
53/F18MCA1201854545IIb12No5
  • Note:—NIHSS indicates the National Institutes of Health Stroke scale; M, male; F, female; MCA, middle cerebral artery; BA, basilar artery; ICAT, internal carotid artery T-bifurcation; IV, intravenous; rtPA, recombinant tissue plasminogen activator; IA, intra-arterial; TICI, Thrombolysis in Cerebral Ischemia; mRS, modified Rankin scale.